- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03469869
Effects of Balanced and Sustainable Diet Application for Insulin Resistance and Inflammation Marker of Obese People
The Effect of Balanced and Sustainable Diet for Insulin Resistance and Inflammation Marker of Obese Adults in Indonesia
This study evaluates the effect of balanced and sustainable diet application on fat composition, insulin resistance and inflammation marker in obese people.
Intervention: Obese subject will receive intervention on balanced and sustainable diet application Control: Obese subject will receive a balanced diet application only
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Maintaining the adherence of weight loss programme while selecting healthy and sustainable foods will become a worldwide future challenge in nutrition. Therefore, we investigated the suitable content, graphic, and flow in developing a mobile application as an alternative solution for enhancing the compliance of weight control and selecting healthy food with the least environmental impact.
The treatment for obesity consists of dieting, physical exercise, pharmacology, and surgery. Restricted balanced diet is a well known diet recommendation for people with obesity. Sustainable diet is an alternative form of diet which contributes to healthy life and is protective of biodiversity.
The main challenge in obesity management is the sustainability of weight loss programme. Mobile apps are an alternative solution for enhancing compliance.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
West Java
-
Depok, West Java, Indonesia, 16424
- University of Indonesia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Body mass index ≥ 25 kg/m2
- using Android-based smartphone
- willing to join this research by signing informed consent
Exclusion Criteria:
- pale in physical examination
- in weight loss program
- have obesity with comorbidities
- have hormonal diseases
- consumed hormonal drug, PTU, anti diabetes drug
- smoking or stop smoking under 2 years
- pregnant and breastfeeding women
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: balanced and sustainable diet
The intervention group will receive menu recommendation of restriction calorie balanced and sustainable diet for 8 weeks.
the control group will receive menu recommendation of balanced diet for 8 weeks.
these menus are given in the apps
|
the intervention group will get menu recommendation of restriction calorie balanced and sustainable diet for 8weeks. the other group will get menu recommendation of balanced diet for 8 weeks. these menus are given in the apps named EatsUp. the intervention group will get menu recommendation of restriction calorie balanced and sustainable diet for 8 weeks. the other group will get menu recommendation of balanced diet for 8 weeks. these menus are given in the apps named EatsUp. |
|
Active Comparator: balanced diet
the intervention group receive get menu recommendation of restriction calorie balanced and sustainable diet for 8 weeks.
the other group will receive menu recommendation of balanced diet for 8 weeks.
these menus are given in the apps
|
the intervention group will get menu recommendation of restriction calorie balanced and sustainable diet for 8weeks. the other group will get menu recommendation of balanced diet for 8 weeks. these menus are given in the apps named EatsUp. the intervention group will get menu recommendation of restriction calorie balanced and sustainable diet for 8 weeks. the other group will get menu recommendation of balanced diet for 8 weeks. these menus are given in the apps named EatsUp. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of body weight
Time Frame: baseline at Day0 and endline at Day56
|
Change from baseline body weight at 8 weeks, is measured in kg
|
baseline at Day0 and endline at Day56
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of Fat Mass
Time Frame: baseline at Day0 and endline at Day56
|
Change from baseline Fat Mass at 8 weeks, is measured by body composition analyzer in kg
|
baseline at Day0 and endline at Day56
|
|
Change of Fasting plasma glucose
Time Frame: baseline at Day0 and endline at Day56
|
Change from baseline Fasting plasma glucose at 8 weeks, is measured in mg/dL
|
baseline at Day0 and endline at Day56
|
|
Change of TNF alpha
Time Frame: baseline at Day0 and endline at Day56
|
Change from baseline TNF alpha at 8 weeks, is measured in pg/ml
|
baseline at Day0 and endline at Day56
|
|
Change of Fasting Insulin
Time Frame: baseline at Day0 and endline at Day56
|
Change from baseline Fasting Insulin at 8 weeks, is measured in µU/mL
|
baseline at Day0 and endline at Day56
|
|
Change of HOMA-IR
Time Frame: baseline at Day0 and endline at Day56
|
Change from baseline HOMA-IR at 8 weeks, is measured using formulation : glukosa (mg/dL) x insulin (µU/mL)/405
|
baseline at Day0 and endline at Day56
|
|
Change of Waist Circumference
Time Frame: baseline at Day0 and endline at Day56
|
Change from baseline Waist Circumference at 8 weeks, is measured in cm
|
baseline at Day0 and endline at Day56
|
|
Change of Carbohydrate intake
Time Frame: baseline at Day0 and endline at Day56
|
Change from baseline Carbohydrate intake at 8 weeks, is measured in gram using 24HR-recall
|
baseline at Day0 and endline at Day56
|
|
Change of Fat intake
Time Frame: baseline at Day0 and endline at Day56
|
Change from baseline Fat intake at 8 weeks, is measured in gram using 24HR-recall
|
baseline at Day0 and endline at Day56
|
|
Change of Protein intake
Time Frame: baseline at Day0 and endline at Day56
|
Change from baseline Protein intake at 8 weeks, is measured in gram using 24HR-recall
|
baseline at Day0 and endline at Day56
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Rina Agustina, PhD, Indonesia University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- YULIA-SAMI project
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammation
-
University of EdinburghUmeå UniversityCompletedSystemic Inflammation | Respiratory InflammationSweden
-
University of AarhusAarhus University Hospital; University of CopenhagenCompletedSystemic Inflammation | Airway InflammationDenmark
-
Sykehuset TelemarkRikshospitalet University Hospital; Helse Sor-OstCompletedAirway Inflammation | Peripheral Blood Inflammation Markers | Cement Dust ExposureNorway
-
Center for Research and Innovation Viña Concha...Universidad Católica del MauleNot yet recruitingInflammaging | Antioxidant Status, Inflammation | Inflammation Biomarkers | Antioxidant Capabilities | Cardiometabolic Health IndicatorsChile
-
University of NebraskaNot yet recruiting
-
Central Hospital, Nancy, FranceRecruiting
-
Oral Science International Inc.AdvarraNot yet recruiting
-
University of NebraskaCompletedPeriodontal InflammationUnited States
-
University of California, DavisCompleted
-
Università degli Studi di BresciaCompletedVitreous Inflammation
Clinical Trials on balanced and sustainable diet
-
University of AlicanteActive, not recruitingObesity | Metabolic Syndrome | Chronic Disease | Frailty | Sarcopenia | AgingSpain
-
Chang Gung Memorial HospitalRecruitingSystemic Lupus Erythematosus | Ketogenic DietingTaiwan
-
University of Roma La SapienzaCompleted
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...UnknownCeliac DiseaseItaly
-
University of GuadalajaraUniversidad de Granada; Tecnológico Nacional de México, campus Ciudad GuzmánActive, not recruitingHyperglycemia | Physical Activity | Body Composition | Blood Pressure | Hypercholesterolemia | Hypertriglyceridemia | Gut Microbiota | HDLC | Eating Behavior | Acanthosis Nigricans | Food Intake | Diet QualityMexico
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
-
University of Veterinary and Animal Sciences, Lahore...RecruitingHealthy AdultsPakistan
-
University College, LondonUniversity College London HospitalsCompletedObesity | Overweight | Cardiometabolic SyndromeUnited Kingdom
-
roberta cazzolaIstituti Clinici di Perfezionamento di Milano; Luigi Sacco University HospitalCompletedMetabolic Syndrome | Obesity, Metabolically BenignItaly
-
Mondelēz International, Inc.Centre de Recherche en Nutrition Humaine Rhone-Alpe; Biofortis Mérieux NutriSciencesCompleted